亚太胰腺癌治疗和诊断市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按癌症类型、治疗(手术、化疗、放射治疗、靶向治疗)、诊断和地理划分

市场快照

Study Period: 2018 - 2026
Base Year: 2021
CAGR: 6.4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

所研究的市场主要受诸如胰腺癌患病率增加、对该疾病的诊断测试和治疗需求增加等因素的推动。因此,许多政府和非营利组织已采取主动行动,在亚太地区传播对胰腺癌的认识。此外,诊断和治疗方面的技术进步带来了更有效的解决方案。这些是推动市场增长的主要因素。

治疗和诊断的高成本以及治疗引起的副作用预计将抑制市场增长。

报告范围

当胰腺的一部分开始不受控制的细胞生长时,就会发生胰腺癌。肿瘤会发展,这些会干扰胰腺的工作方式。胰腺癌治疗和诊断涉及成功诊断和治疗胰腺癌的程序。

在报告中,提供了对亚太地区胰腺癌治疗和诊断市场的详细分析。通过整理跨部门产生的收入来评估市场,这些收入按癌症类型、治疗、诊断和地理分类。

By Type
By Treatment
Surgery
Chemotherapy
Radiation Therapy
Targeted Therapy
By Diagnostics
Imaging
Biopsy
Endoscopy
Other Diagnostic Tests
By Cancer Type
Exocrine Cancers
Endocrine Cancers
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

主要市场趋势

放射治疗有望实现高复合年增长率

放射疗法是一种癌症治疗方法,它使用高能辐射,以波(如 X 射线)或粒子(如质子)的形式来杀死癌细胞或阻止它们生长和分裂。放射治疗可以防止胰腺肿瘤生长,有时可以缩小它们。由于放射治疗针对特定(集中)区域,因此被认为是局部治疗。

正如 Noorazrul Yahya 等人在亚太临床肿瘤学杂志上发表的 2018 年报告所述,亚太地区对放射治疗的需求预计也会增加。根据该报告的估计,预计 2025 年和 2035 年所需的放射治疗分数将分别增加到 1110 万和 1410 万,而东南亚 2015 年为 760 万。

随着需求的增加,预计其在胰腺癌中的应用也会增加。预计这将有助于该地区的市场增长。

Graph

竞争格局

亚太地区大部分国家都是发展中国家。这些发展中经济体的胰腺癌患病率越来越高。因此,这些国家对于全球参与者进入市场来说是非常有利可图的。因此,该地区拥有胰腺癌治疗和诊断市场中全球最大的参与者。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence and Prevalence of Pancreatic Cancer

      2. 4.2.2 Rising Awareness and Concern about the Disease

      3. 4.2.3 Technological Advancements and Innovation of New Products

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs Associated with Treatment and Diagnosis

      2. 4.3.2 Side Effects of Pancreatic Cancer Therapy

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 By Treatment

        1. 5.1.1.1 Surgery

        2. 5.1.1.2 Chemotherapy

        3. 5.1.1.3 Radiation Therapy

        4. 5.1.1.4 Targeted Therapy

      2. 5.1.2 By Diagnostics

        1. 5.1.2.1 Imaging

        2. 5.1.2.2 Biopsy

        3. 5.1.2.3 Endoscopy

        4. 5.1.2.4 Other Diagnostic Tests

    2. 5.2 By Cancer Type

      1. 5.2.1 Exocrine Cancers

      2. 5.2.2 Endocrine Cancers

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 China

        2. 5.3.1.2 Japan

        3. 5.3.1.3 India

        4. 5.3.1.4 Australia

        5. 5.3.1.5 South Korea

        6. 5.3.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bristol-Myers Squibb

      2. 6.1.2 Canon Medical Systems

      3. 6.1.3 Eli Lilly and Company

      4. 6.1.4 F. Hoffmann-La Roche AG

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Hitachi Medical

      7. 6.1.7 Novartis AG

      8. 6.1.8 Pfizer Inc

      9. 6.1.9 Philips Healthcare

      10. 6.1.10 Siemens AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market market is studied from 2018 - 2026.

The Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market is growing at a CAGR of 6.4% over the next 5 years.

Bristol-Myers Squibb, Novartis AG, F. Hoffmann-La Roche AG, Pfizer Inc, Eli Lilly and Company are the major companies operating in Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!